Innovating sleep apnoea care
Sleep apnoea is a potentially serious condition but only one in five patients are in care.
Oventus (ASX:OVN) is innovating sleep apnoea care with its patented airway design that creates a 'second nose'. Using CAD software to create a 3D drawing of the patient’s mouth and bite, Oventus uses 3D printing technology to manufacture these custom-made medical-grade mouthguards from titanium.
Getting the most from your roadshow
Half yearly reporting season for ASX listed companies with a 30 June year end has just finished up. For IR Department, the start of March typically signals the time when our smaller ASX listed company clients would want to roadshow. Some companies, however, will be deliberating over how important roadshows are.
Why M&A is a major investment theme for 2018
Around 22,000 people attended the JP Morgan Healthcare Conference 2018 in San Francisco.
Australian broker Paul Kelly has attended the conference for the past five years. Speaking to Health Invest TV in an interview with IR Department's Managing Director, Jane Lowe, Paul gives you a first-hand account of what happens over the week.
New LinkedIn features you should care about
LinkedIn plays a pivotal role in our communication strategies because it’s the biggest B2B social marketing platform out there.
Whether or not you should be using LinkedIn is a subject for another day – right now we just want to tell you about two new features that small to mid capped companies should care about.
How small caps can communicate better with investors: Three tips from an award-winning financial planner
3 key things an analyst looks at when researching a small company
There is a reason ‘small cap’ specialists are engaged to invest in small cap stocks - there are some key areas of focus for small stock investing that are often taken for granted in large cap investing.
IR Department senior consultant John Burgess has almost 20 years’ experience as an analyst across a range of sectors and companies. John explores three key focus areas of analysis that differ between small and large cap stocks. If you're a small company, it pays to bear these in mind when undertaking investor relations.
How useful is independent research? Heard of MiFID II?
IR Department and DEC PR support Skyfii (ASX: SKF)
AdAlta's Sam Cobb on the company's unique antibody platform
Novogen's Dr James Garner explores the company's transformation
Innovations, with David Langford
Today on Swings and Roundabouts, David Langford, Managing Director and Chief Investment Analyst with Long Lake Research speaks with Jane Lowe about contrarian investing and the need for Australian companies to innovate or get left behind.
Market Report - with Matt Felsman
Introducing Swings and Roundabouts
Putting on your PM hat
Perspectives from the chair: An interview with David Gonski AC FAICDLife
What we look for in companies - Glennon Capital
If the CEO Behaves Badly, Then What?
We've all read about them - scandals and examples of inappropriate conduct where CEOs (or other senior company members) were involved. The question is, in a situation where the behaviour is inappropriate, but is not illegal, what is the right way to handle it? And what are the consequences of mismanagement?
Investing in IPOs
Lessons Learned from publishing on LinkedIn
Whether we like it or not, social media has become an area that listed companies need to know about. The fact is, even if you're not actively participating in social media, if you're a listed company, people are most likely talking about you in the social media space.